Zobrazeno 1 - 10
of 25
pro vyhledávání: '"D. Kamanabrou"'
Autor:
D. Kamanabrou, J. Bonneterre, Philippe Saiag, J. Fra, V. Guillem Porta, A. Scherrer, Y. Menu, J. L.Gonzalez Larriba, Michael Weichenthal, Marie-Françoise Avril, Jean-Jacques Grob, T. Bieber, K. Neuber, J. Sufliarsky, Jean Jacques Bonerandi, Hubert Pehamberger, K. Gilde, Peter Mohr, Steinar Aamdal, Axel Hauschild
Publikováno v:
Journal of Clinical Oncology. 22:1118-1125
Purpose To compare fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, duration of responses, time to progression, time to occurrence of brain metastases (BM), and to assess safety and
Autor:
J Atzpodien, C Neumann, Thomas M. Rünger, Michael Fluck, I Müller, M Reitz, P von den Driesch, D. Kamanabrou, T Patzelt, Gerhard Schuler, K Neuber, E Paul, Eva-B. Bröcker
Publikováno v:
British Journal of Cancer
Metastatic melanoma responds poorly to the currently available chemotherapeutic agents and, until today, no standard treatment has been established. Most single agent chemotherapeutics provide only low response rates. Dacarbazine (DTIC), the most act
Autor:
D. Kamanabrou, M. Semik, Hideo A. Baba, Markus Rothenburger, N. Roos, H. H. Scheld, Andreas Hoffmeier, Christoph Schmidt
Publikováno v:
The Thoracic and cardiovascular surgeon. 50(1)
In this communication, we will present a very rare case of the coexistence of non-Hodgkin's lymphoma (NHL; low malignant lymphocytic lymphoma of the B-cell type) and a non-small-cell lung carcinoma (NSCLC). A patient with a 15-year history of NHL dev
Autor:
D, Kamanabrou
Publikováno v:
Praxis. 90(10)
The prognosis of stage IV melanoma is unfavourable compared to the curative surgical results in early stage. The median survival amounts to 8-10 months and only 1-2% of the patients will not relapse. Dacarbazine remains the reference standard treatme
Publikováno v:
Fortschritte der operativen und onkologischen Dermatologie ISBN: 9783642793370
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30eb4088891d76f9102a98626151b58b
https://doi.org/10.1007/978-3-642-79336-3_29
https://doi.org/10.1007/978-3-642-79336-3_29
Publikováno v:
Oncology research. 7(7-8)
Expression of mutant p53 detected by immunohistochemistry has been described in human malignant melanoma, but there are few reports of molecular analyses. To investigate the genetic basis for p53 expression in malignant melanoma, we examined 58 prima
Autor:
D, Kamanabrou
Publikováno v:
European journal of cancer (Oxford, England : 1990).
Three double-blind, dose-ranging studies, involving 996 chemotherapy-naive patients, were conducted to determine the optimal prophylactic dose of intravenous (i.v.) granisetron for prevention of cytotoxic-induced emesis. The antiemetic efficacy of pr
Publikováno v:
Melanoma Research. 14:A15
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.